Dexmedetomidine Hydrochloride — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Dexmedetomidine Hydrochloride. We track 21 distinct Drug Identification Numbers (DINs) for this molecule, of which 14 are currently in marketed status. Across those registrations there are 14 manufacturers or marketing authorization holders, 2 dosage forms, and 6 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Dexmedetomidine Hydrochloride in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Dexmedetomidine Hydrochloride product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Dexmedetomidine Hydrochloride
Dosage forms: Solution, Gel. Strengths: 0.5 MG, 100 MCG, 400 MCG, 200 MCG, 4 MCG, 0.1 MG.
Manufacturers and marketing authorization holders
ORION CORPORATION, DECHRA VETERINARY PRODUCTS INC., AURO PHARMA INC, SANDOZ CANADA INCORPORATED, ACCORD HEALTHCARE INC, EUGIA PHARMA INC., HIKMA CANADA LIMITED, JUNO PHARMA CANADA INC., BAXTER CORPORATION, OMEGA LABORATORIES LIMITED, FRESENIUS KABI CANADA LTD, MODERN VETERINARY THERAPEUTICS LLC, PFIZER CANADA ULC, GREY WOLF ANIMAL HEALTH INC.
Registered products containing Dexmedetomidine Hydrochloride
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 02333929 | DEXDOMITOR | ORION CORPORATION | 0.5 MG | Solution | Marketed |
| 02524945 | DEXMEDESED | DECHRA VETERINARY PRODUCTS INC. | 0.5 MG | Solution | Marketed |
| 02464381 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | AURO PHARMA INC | 100 MCG | Solution | Marketed |
| 02493314 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | SANDOZ CANADA INCORPORATED | 100 MCG | Solution | Cancelled Pre Market |
| 02477327 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | ACCORD HEALTHCARE INC | 100 MCG | Solution | Marketed |
| 02528886 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION | EUGIA PHARMA INC. | 100 MCG | Solution | Marketed |
| 02537095 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP | HIKMA CANADA LIMITED | 100 MCG | Solution | Approved |
| 02467976 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | JUNO PHARMA CANADA INC. | 100 MCG | Solution | Marketed |
| 02513978 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | BAXTER CORPORATION | 100 MCG | Solution | Marketed |
| 02539152 | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP | OMEGA LABORATORIES LIMITED | 100 MCG | Solution | Cancelled Pre Market |
| 02539470 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | 400 MCG | Solution | Cancelled Pre Market |
| 02487365 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | JUNO PHARMA CANADA INC. | 200 MCG | Solution | Marketed |
| 02536463 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | FRESENIUS KABI CANADA LTD | 4 MCG | Solution | Approved |
| 02537109 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | HIKMA CANADA LIMITED | 4 MCG | Solution | Marketed |
| 02539462 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | OMEGA LABORATORIES LIMITED | 200 MCG | Solution | Cancelled Pre Market |
| 02487373 | DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | JUNO PHARMA CANADA INC. | 400 MCG | Solution | Marketed |
| 02483947 | DEXVETIDINE | MODERN VETERINARY THERAPEUTICS LLC | 0.5 MG | Solution | Marketed |
| 02339366 | PRECEDEX | PFIZER CANADA ULC | 100 MCG | Solution | Cancelled Post Market |
| 02437147 | PRECEDEX | PFIZER CANADA ULC | 4 MCG | Solution | Marketed |
| 02492431 | SEDAJECT | GREY WOLF ANIMAL HEALTH INC | 0.5 MG | Solution | Marketed |
| 02530392 | SILEO | ORION CORPORATION | 0.1 MG | Gel | Marketed |
Sourcing Dexmedetomidine Hydrochloride through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Dexmedetomidine Hydrochloride we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Dexmedetomidine Hydrochloride and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.